Purchase Order FA481423P0060
Award Date 8/4/23
Potential Completion Date 8/3/28
Potential Value $180K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Ashburn, VA 20148, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
SBIR Program Phase III Action
Primary Consortia Member
Not listed Similar Awards
- This contract award is for the delivery of various shortage pharmaceuticals to the Defense Health Agency, an agency within the Department of Defense. The prime contractor, The Compounding Center Inc., is a minority-owned, small disadvantaged business that provides specialized pharmaceutical compounds and medical supplies to government agencies. The contract is a blanket purchase agreement with a ceiling value of $300,000.00, allowing for the expedited acquisition of customized medications and...
- This federal contract award was granted to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency's (DLA) Medical Supply Chain division. The $118,406.60 firm fixed-price delivery order is for the supply of various pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. These products are to support the recurring medical supply needs of military...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $16,303.22 firm fixed-price delivery order is for the supply of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. This award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which enables the company to fulfill recurring...
- This federal contract award is for the delivery of Mounjaro (tirzepatide) 15 mg/0.5 ml pens, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $3,156 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a child contract under a larger Indefinite Delivery Contract (IDC) vehicle held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a delivery order with a ceiling value of $4,736.00. The award was made by the Defense Logistics Agency (DLA), a defense agency, to fulfill the recurring medical supply needs of military health facilities worldwide. The contract covers a wide range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, provides a wide range of pharmaceutical products and medical supplies to support the recurring medical needs of the Department of Defense (DoD) and Department of Veterans Affairs (VA) health facilities nationwide. The $11,089.08 firm fixed-price delivery order is issued under a larger $499,999,999 indefinite delivery contract (IDC) with the Defense Logistics Agency's Medical...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a firm fixed-price delivery order valued at $24,623.65. The award was made by the Medical Supply Chain division of the Defense Logistics Agency (DLA), a defense agency, to support the recurring pharmaceutical and medical supply needs of military health facilities worldwide. The contract covers a wide range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a firm fixed-price delivery order valued at $11,587.21. The award was made by the Defense Logistics Agency (DLA) under the Medical Supply Chain program to provide a wide range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support the recurring medical supply needs of military...
- This federal contract award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp with the Defense Logistics Agency (DLA) Troop Support Medical. The IDC, valued up to $999,999,999.00 through December 31, 2025, enables the DLA to efficiently procure a comprehensive range of pharmaceutical products and medical supplies for military treatment programs and facilities worldwide. The specific delivery order, valued at $1,315.00, is for the...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, provides pharmaceutical products and medical supplies to the U.S. Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare facilities. The $48,171.42 fixed-price delivery order contract covers a wide range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. This award is part of a larger...
This contract award to Montuno Health, Inc., a minority-owned small disadvantaged business, provides $179,940 for the DOSEPHARM Pharmacy Application Platform under the SBIR (Small Business Innovation Research) Phase III program. The Defense Health Agency, an agency within the Department of Defense, issued this firm-fixed-price purchase order for the development of digital health solutions to enhance patient medication management and care. The award builds upon Montuno Health's prior SBIR Phase II and Phase I contracts, demonstrating the company's expertise in delivering innovative healthcare technology to government clients. This contract does not have a set-aside designation, indicating it was awarded through an unrestricted competition.
Generated 11/21/24, 9:22 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00003 | Other Administrative Action | $0 | 8/22/24 | |
| P00002 | Other Administrative Action | $0 | 8/12/24 | |
| P00001 | Exercise an Option | $30.0k | 8/1/24 | |
| Not listed | Not listed | $24.0k | 8/3/23 |